nephrologylinx Medical News about Reduced Albuminuria with Sarpogrelate

Nephrology

Become a Member Today!

Email
Password
Remember me
Forgot your Password?
Invite Code?

Home
General Nephrology

Messages

Conferences

Jobs

Newsletters

My Library

Topics in
Nephrology

Acid-Base

Basic Science/Genetics

Chronic Dz/Renal Failure

Cystic Dz

Dialysis

Economics of Medicine

Endocrinology

Fluids and Electrolytes

Glomerular/Tubular Dz

Hematology/Oncology

Hypertension

Nephropathies

Pediatric Nephrology

Pharmacology/kinetics

Popular Press

Radiology/Diagnostics

Stone Disease

Transplantation

Ureteral Disease

Vascular

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

Sponsor

Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website

Reduced Albuminuria with Sarpogrelate Is Accompanied by a Decrease in Monocyte Chemoattractant Protein-1 Levels in Type 2 Diabetes
Clinical Journal of the American Society of Nephrology, 04/03/08

Email This Article

Save in My Library

Free Abstract

Ogawa S et al. - Sarpogrelate can reduce albuminuria and plasma and urinary monocyte chemoattractant protein-1 levels while increasing plasma adiponectin in diabetic nephropathy. These effects seem to be mediated via mechanisms that are different from those of angiotensin II receptor blocker or thiazolidinedione.

Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT

Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology

Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse

Medical Students
Nurse Practitioner
Pharma/Drug Marketer

Pharmacist
Physician
Physician Assistants

Article Search

Keyword:

Search:

Published within:

Sort By:
Date Relevance

Sponsor